Welcome to LookChem.com Sign In|Join Free

CAS

  • or
3-Benzofurancarboxylic acid, 6-hydroxy-2-Methyl-, Methyl ester, commonly known as esculetin, is a chemical compound derived from natural sources such as the bark of the American and European white elm trees. It is a coumarin derivative that has been studied for its potential therapeutic effects, including anti-inflammatory, antioxidant, and anticancer properties. Esculetin is also utilized in cosmetic and skincare products due to its potential skin lightening and anti-aging effects. Further research is required to fully understand its mechanisms of action and potential applications in the medical and cosmetic fields.

638218-70-9

Post Buying Request

638218-70-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

638218-70-9 Usage

Uses

Used in Pharmaceutical Applications:
Esculetin is used as a therapeutic agent for its anti-inflammatory, antioxidant, and anticancer properties. It has been investigated for its potential to modulate various biological pathways and exert inhibitory effects on tumor growth and progression.
Used in Cosmetic and Skincare Industry:
Esculetin is used as an active ingredient in cosmetic and skincare products for its potential skin lightening and anti-aging effects. It may contribute to improving skin appearance and reducing signs of aging.
Used in Research and Development:
Esculetin is utilized in research and development for its potential health benefits and applications in various industries. Further studies are needed to explore its mechanisms of action, efficacy, and safety profile in different therapeutic areas.

Check Digit Verification of cas no

The CAS Registry Mumber 638218-70-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,3,8,2,1 and 8 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 638218-70:
(8*6)+(7*3)+(6*8)+(5*2)+(4*1)+(3*8)+(2*7)+(1*0)=169
169 % 10 = 9
So 638218-70-9 is a valid CAS Registry Number.

638218-70-9Relevant articles and documents

Novel and convenient synthesis of benzofurans from dihydrocoumarins

Shachan-Tov, Sharona,Frimer, Aryeh A.

, p. 905 - 908 (2012)

7-Hydroxy-3,4-dihydrocoumarin-4-carboxylic acid (7), conveniently prepared from m-resorcinol and maleic anhydride, was surprisingly transformed by acid anhydride and pyridine into the corresponding ketone, 4-alkanoyl analog 11. The latter reacted in turn

Metal and oxidant-free Br?nsted acid-mediated cascade reaction to substituted benzofurans

Mari, Giacomo,Ciccolini, Cecilia,De Crescentini, Lucia,Favi, Gianfranco,Santeusanio, Stefania,Mancinelli, Michele,Mantellini, Fabio

, p. 10814 - 10824 (2019)

Substituted hydroxy-benzofurans are easily accessible by treatment of resorcinols and 1,2-diaza-1,3-dienes (DDs) under acidic conditions. The reaction happens through an uncommon Michael reaction between aromatic derivatives as aromatic C(sp2)-

Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use

-

, (2008/06/13)

The invention relates to compounds represented by the formula I and to prodrugs or metabolites thereof, or pharmaceutically acceptable salts or solvates of said compounds, said prodrugs, and said metabolites, wherein Z, Y, R11 and R14, R15, R16, and R17 are as defined herein. The invention also relates to pharmaceutical compositions containing the compounds of formula I and to methods of treating hyperproliferative disorders in a mammal by administering the compounds of formula I.

BENZOFUSED HETEROARYL AMIDE DERIVATIVES OF THIENOPYRIDINES USEFUL AS THERAPEUTIC AGENTS, PHARMACEUTICAL COMPOSITIONS INCLUDING THE SAME, AND METHODS FOR THEIR USE

-

Page 122, (2010/02/04)

The invention relates to compounds represented by the formula I and to prodrugs or metabolites thereof, or pharmaceutically acceptable salts or solvates of said compounds, said prodrugs, and said metabolites, wherein Z, Y, R11 and R14, R15, R16, and R17 are as defined herein. The invention also relates to pharmaceutical compositions containing the compounds of formula I and to methods of treating hyperproliferative disorders in a mammal by administering the compounds of formula I.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 638218-70-9